Vaccine

Need help? Contact us We've detected unusual activity from your computer network To continue, please click the box below to let us know you're not a robot. Why did this happen? Please make sure your browser supports JavaScript and cookies and that you are not blocking them from loading. For more information you can review…

May 27, 2020 | 9:12am | Updated May 27, 2020 | 9:34am Nikolai Petrovsky Flinders University The P4 laboratory at the Wuhan Institute of Virology. AFP via Getty Images Up Next You ask, we answer. The Post is fielding questions from... The coronavirus that causes COVID-19 is “almost perfectly human adapted” — lending credence to…

The desperate hunt for treatments and vaccines has changed how researchers, regulators, drug companies like Moderna, investors and journalists do their jobs.Hours after announcing positive results from a small trial of its coronavirus vaccine, Moderna Therapeutics unveiled a stock offering that sought to raise $1.3 billion.Credit...Brian Snyder/ReutersMay 23, 2020Updated 12:00 p.m. ETWhen the biotech company…

Coronavirus vaccine candidate Ad5-nCoV from Chinese pharmaceutical company CanSino is both safe and effective, according to the results of a Phase 1 clinical trial. Researchers looking at 108 healthy volunteers who received the test drug in mid-March found the vaccine generates the kind of immune response that can kill the novel coronavirus. The side-effects were…

Home News (Image: © Shutterstock) A potential coronavirus vaccine developed in China appeared safe and able to generate an immune response after an early trial in more than 100 people, according to a new study.The vaccine, called Ad5-nCoV, is being developed by the Chinese company CanSino Biologics, and was one of the first coronavirus vaccines…